Rx Medicare

Hypogonadism, also known as testosterone deficiency, affects 4-5 million men in the United States placing them at risk for developing osteoporosis. Despite the clear association of testosterone deficiency with low bone density and osteoporosis, Medicare does not provide coverage for bone density testing for these individuals. To address this concern, today The Endocrine Society issued a

Read More…

Related Posts

• Proposal Calls For Medicare Coverage Of HIV Screening
• Statement By Medicare Rights Center President Joe Baker On Reduced State “Clawback” Payments For Medicare Drug Coverage
• With Health Reform Stalled, Medicare Coverage For Some Therapies Subject To Caps
• Medicare Fraud Round-Up: N.D. Beneficiaries Getting Illegal Phone Calls, Doctor Indicted In Ohio
• Medicare To Pay For HIV Testing
• Coburn Opposes Medicare Part B Premiums Freeze, McCain Calls Drug Pact ‘Unsavory’
• ASCO Calls On Medicare To Abandon Proposed Cuts To Cancer Care
• Secretary Sebelius Releases New Report: America’s Seniors And Health Insurance Reform: Protecting Coverage And Strengthening Medicare
• Extended Medicare Safety Net Bill, Australia
• Alzheimer’s Patients Fight For Quicker Medicare Coverage
• President Calls For Medicare Payment Rate Revisions
• Senate Bill To Protect Patients’ Healthcare By Amending Medicare Coverage
• Los Angeles Times Examines Debate Over Medicare Coverage For Virtual Colonoscopies
• Medicare Expands Coverage Of PET Scans As Cancer Diagnostic Tool
• BlueCross BlueShield Association Calls For Changes To Proposed Medicare Advantage Cuts, Rep Boehner Criticizes Proposed Limits On Home Oxygen Supplies

Tags: bone, calls, coverage, deficiency, density, easing, endocrine, extended, medicare, society, testing, testosterone

This entry was posted on Thursday, August 20th, 2009 at 11:08 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.